Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7540841rdf:typepubmed:Citationlld:pubmed
pubmed-article:7540841lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0227578lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0031667lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0034791lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0086376lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0220905lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C1948027lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:7540841lifeskim:mentionsumls-concept:C0767337lld:lifeskim
pubmed-article:7540841pubmed:issue2lld:pubmed
pubmed-article:7540841pubmed:dateCreated1995-7-24lld:pubmed
pubmed-article:7540841pubmed:abstractTextA non-hydrolysable guanosine nucleotide analog, GTP[S] at 200 microM, stimulated amylase secretion which was inhibited by an anti-phospholipase A2 (PLA2) antibody in permeabilized pancreatic acini, indicating that the PLA2 pathway is linked to the GTP binding protein. A high affinity cholecystokinin (CCK) receptor agonist, CCK-OPE (10 microM), and a low affinity receptor agonist, CCK-8 (0.1 microM), both caused amylase secretion in permeabilized cells. The action of CCK-OPE was abolished by the G beta antibody but not by the G alpha-q,11 antibody, whereas the opposite was true of the CCK-8 response. Biscoclaurine alkaloid isotetrandrine (10 microM), a specific inhibitor of PLA2-coupled G proteins, abolished Ca2+ oscillations and amylase secretion induced by CCK-OPE (0.1-100 nM), but not by CCK-8 (10 pM) in intact acini. Gp antagonist-2A (10 microM), which inhibits the activation of Gq, also inhibited the actions of CCK-OPE (10 pM-1 microM) in intact acini. These observations indicate that the functional unit of the heterotrimeric G protein coupled to the high affinity CCK receptor appears to be different from that linked to the low affinity CCK receptor/Gq-alpha pathway. The regulatory site of this G protein coupled to the high affinity CCK receptor is on the beta subunit of Gq protein which elicits Ca2+ oscillations and monophasic amylase secretion via the PLA2 pathway.lld:pubmed
pubmed-article:7540841pubmed:languageenglld:pubmed
pubmed-article:7540841pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:citationSubsetIMlld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7540841pubmed:statusMEDLINElld:pubmed
pubmed-article:7540841pubmed:monthJunlld:pubmed
pubmed-article:7540841pubmed:issn0006-291Xlld:pubmed
pubmed-article:7540841pubmed:authorpubmed-author:TsunodaYYlld:pubmed
pubmed-article:7540841pubmed:authorpubmed-author:OwyangCClld:pubmed
pubmed-article:7540841pubmed:issnTypePrintlld:pubmed
pubmed-article:7540841pubmed:day15lld:pubmed
pubmed-article:7540841pubmed:volume211lld:pubmed
pubmed-article:7540841pubmed:ownerNLMlld:pubmed
pubmed-article:7540841pubmed:authorsCompleteYlld:pubmed
pubmed-article:7540841pubmed:pagination648-55lld:pubmed
pubmed-article:7540841pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:meshHeadingpubmed-meshheading:7540841-...lld:pubmed
pubmed-article:7540841pubmed:year1995lld:pubmed
pubmed-article:7540841pubmed:articleTitleThe regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.lld:pubmed
pubmed-article:7540841pubmed:affiliationDepartment of Internal Medicine, University of Michigan, Ann Arbor 48109, USA.lld:pubmed
pubmed-article:7540841pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7540841pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7540841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7540841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7540841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7540841lld:pubmed